StockVS

Churchill Capital Corp IX (CCIX) 股票分析

金融服务

Churchill Capital Corp IX

$10.78

+$0.00 (+0.00%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Churchill Capital Corp IX operates primarily as a special purpose acquisition company (SPAC) within the financial services sector, specifically focusing on shell companies that do not yet have significant operational activities. Its core business model is dedicated to effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more target businesses rather than engaging in traditional revenue-generating operations. As of the latest data, the company holds a market capitalization of $392.29 million, while its annual revenue is not available for reporting, and the number of employees is listed as N/A. The absence of reported revenue figures combined with a market cap of $392.29 million indicates that the company's valuation is derived almost exclusively from its shell status and potential future merger targets rather than current cash flows or operational earnings.

财务健康

The company reports a net income of $8.56 million for the trailing twelve months, whereas revenue and EBITDA figures are not available, creating a scenario where profitability metrics appear disconnected from traditional top-line growth indicators. This discrepancy suggests a cost structure heavily reliant on non-operational income sources or specific accounting treatments common for SPACs prior to a business combination, as the gap between the reported net income and the unavailable revenue implies earnings are not driven by standard sales volumes. The free cash flow stands at -$2,085,372, which indicates a net cash outflow that limits the company's immediate financial flexibility for organic expansion without external financing or a successful merger. All three margin metrics—the gross margin, operating margin, and profit margin—are reported at 0.0%, reflecting the lack of significant operational activities and the absence of traditional cost-of-goods-sold or operating expense dynamics found in active businesses. Regarding liquidity, the company holds $2,469 in cash against $0 in debt, resulting in a debt-to-equity ratio that is not available, yet the zero debt load suggests a conservative balance sheet structure devoid of leverage. The current ratio is 0.94, which indicates that current assets fall slightly short of covering current liabilities, signaling a tight but manageable short-term liquidity position typical for entities awaiting a merger transaction. Return on Equity and Return on Assets are reported as N/A and -0.8% respectively, revealing that management is currently generating a negative return on assets, which is consistent with an entity that has not yet acquired a revenue-producing business.

估值评估

The trailing twelve-month P/E ratio is 46.52, while the forward P/E is not available, implying that the market is pricing in significant uncertainty regarding future earnings growth since the forward metric cannot be calculated without projected net income. The price-to-book ratio stands at -38.91, a negative figure that indicates the market capitalization is valued significantly below the company's net asset book value, a distortion often seen in SPACs where the trust account value exceeds the stock price or where the book value calculation includes liabilities that outweigh assets in a pre-merger state. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are not available, which suggests that traditional valuation frameworks used for operating companies are inapplicable given the lack of sales and EBITDA data. The stock has traded within a 52-week range with a high of $11.66 and a low of $10.45; without a specific current price provided in the facts, the absolute trading position relative to this range cannot be numerically defined, but the narrow spread of just $1.21 suggests low volatility in recent trading sessions. The beta value is not available, making it impossible to quantify the stock's price volatility relative to the broader market, though the narrow 52-week price range implies limited price movement compared to more volatile equities.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are reported as N/A and -18.4% respectively, indicating that while earnings have contracted by 18.4% from the prior year, revenue growth data is unavailable to determine if earnings are growing faster or slower than revenue. Since the company does not pay dividends, the dividend yield and payout ratio are both N/A and 0.0%, meaning the company reinvests its earnings into the SPAC structure to fund a future merger rather than distributing cash to shareholders. The negative earnings growth of -18.4% highlights a contraction in profitability, likely driven by changes in trust account valuations or transaction costs rather than operational inefficiencies. Overall, the company presents a profile of a transitional financial vehicle with no current dividend income, negative earnings growth, and valuation metrics that rely on potential future business combinations rather than historical financial performance or current growth rates.

同行比较

Churchill Capital Corp IX (CCIX) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Churchill Capital Corp IX CCIX $395.22M 53.9
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。Churchill Capital Corp IX的市盈率为53.9。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Churchill Capital Corp IX

Churchill Capital Corp IX does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Churchill Capital Corp IX was incorporated in 2023 and is based in New York, New York.

公司简介以英文显示。

访问官网 →

关键指标

市值
$395.22M
市盈率
53.90
52周最高
$11.42
52周最低
$10.45
平均成交量
141.92K

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States